Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
Identifieur interne : 000B42 ( Istex/Corpus ); précédent : 000B41; suivant : 000B43Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
Auteurs : Mahmud Tareq Hassan KhanSource :
- Topics in Heterocyclic Chemistry [ 1861-9282 ]
Abstract
Abstract: Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological activities, including on different types of cancers. This chapter begins by reviewing some general aspects of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter then details several of the latest findings on the activities of quindoline analogs against a number of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these analogs, which were proposed by subsequent authors, are also discussed.
Url:
DOI: 10.1007/7081_2007_087
Links to Exploration step
ISTEX:E321B47C791B292DD530740F5E0888E20ACF93F8Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title><author><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name><affiliation><mods:affiliation>School of Molecular and Structural Biology, and Department of Pharmacology, Institute of Medical Biology, University of Tromsø, 9037, Tromsø, Norway</mods:affiliation></affiliation><affiliation><mods:affiliation>Pharmacology Research Lab., Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: mahmud.khan@fagmed.uit.no</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E321B47C791B292DD530740F5E0888E20ACF93F8</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1007/7081_2007_087</idno><idno type="url">https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000B42</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B42</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title><author><name sortKey="Khan, Mahmud Tareq Hassan" sort="Khan, Mahmud Tareq Hassan" uniqKey="Khan M" first="Mahmud Tareq Hassan" last="Khan">Mahmud Tareq Hassan Khan</name><affiliation><mods:affiliation>School of Molecular and Structural Biology, and Department of Pharmacology, Institute of Medical Biology, University of Tromsø, 9037, Tromsø, Norway</mods:affiliation></affiliation><affiliation><mods:affiliation>Pharmacology Research Lab., Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: mahmud.khan@fagmed.uit.no</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="s" type="main" xml:lang="en">Topics in Heterocyclic Chemistry</title><idno type="ISSN">1861-9282</idno><idno type="eISSN">1861-9290</idno><idno type="ISSN">1861-9282</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1861-9282</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological activities, including on different types of cancers. This chapter begins by reviewing some general aspects of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter then details several of the latest findings on the activities of quindoline analogs against a number of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these analogs, which were proposed by subsequent authors, are also discussed.</div></front></TEI><istex><corpusName>springer-ebooks</corpusName><author><json:item><name>Mahmud Tareq Hassan Khan</name><affiliations><json:string>School of Molecular and Structural Biology, and Department of Pharmacology, Institute of Medical Biology, University of Tromsø, 9037, Tromsø, Norway</json:string><json:string>Pharmacology Research Lab., Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh</json:string><json:string>E-mail: mahmud.khan@fagmed.uit.no</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Angiogenesis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Cancer</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Isoquinoline</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Quindoline</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Quinoline</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Skraup synthesis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Telomerase</value></json:item></subject><arkIstex>ark:/67375/HCB-S6G7H1NF-0</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>OriginalPaper</json:string></originalGenre><abstract>Abstract: Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological activities, including on different types of cancers. This chapter begins by reviewing some general aspects of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter then details several of the latest findings on the activities of quindoline analogs against a number of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these analogs, which were proposed by subsequent authors, are also discussed.</abstract><qualityIndicators><score>6.411</score><pdfWordCount>3391</pdfWordCount><pdfCharCount>22077</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>17</pdfPageCount><pdfPageSize>439 x 666 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>85</abstractWordCount><abstractCharCount>598</abstractCharCount><keywordCount>7</keywordCount></qualityIndicators><title>Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title><chapterId><json:string>87</json:string><json:string>Chap6</json:string></chapterId><genre><json:string>research-article</json:string></genre><serie><title>Topics in Heterocyclic Chemistry</title><language><json:string>unknown</json:string></language><copyrightDate>2007</copyrightDate><issn><json:string>1861-9282</json:string></issn><eissn><json:string>1861-9290</json:string></eissn></serie><host><title>Bioactive Heterocycles V</title><language><json:string>unknown</json:string></language><copyrightDate>2007</copyrightDate><doi><json:string>10.1007/978-3-540-73406-2</json:string></doi><issn><json:string>1861-9282</json:string></issn><eissn><json:string>1861-9290</json:string></eissn><eisbn><json:string>978-3-540-73406-2</json:string></eisbn><bookId><json:string>978-3-540-73406-2</json:string></bookId><isbn><json:string>978-3-540-73405-5</json:string></isbn><volume>11</volume><pages><first>213</first><last>229</last></pages><genre><json:string>book-series</json:string></genre><editor><json:item><name>Mahmud Tareq Hassan Khan</name></json:item></editor><subject><json:item><value>Chemistry and Materials Science</value></json:item><json:item><value>Chemistry</value></json:item><json:item><value>Organic Chemistry</value></json:item><json:item><value>Biochemistry, general</value></json:item><json:item><value>Medicinal Chemistry</value></json:item></subject></host><ark><json:string>ark:/67375/HCB-S6G7H1NF-0</json:string></ark><publicationDate>2007</publicationDate><copyrightDate>2007</copyrightDate><doi><json:string>10.1007/7081_2007_087</json:string></doi><id>E321B47C791B292DD530740F5E0888E20ACF93F8</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title></titleStmt><publicationStmt><authority>ISTEX</authority><availability><licence>Springer-Verlag Berlin Heidelberg</licence></availability><date when="2007">2007</date></publicationStmt><notesStmt><note type="content-type" subtype="research-article" source="OriginalPaper" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="publication-type" subtype="book-series" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0G6R5W5T-Z">book-series</note></notesStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title><author role="corresp"><persName><forename type="first">Mahmud</forename><forename type="first">Tareq</forename><forename type="first">Hassan</forename><surname>Khan</surname></persName><email>mahmud.khan@fagmed.uit.no</email><affiliation><orgName type="department">School of Molecular and Structural Biology, and Department of Pharmacology</orgName><orgName type="institution">Institute of Medical Biology</orgName><address><street>University of Tromsø</street><postCode>9037</postCode><settlement>Tromsø</settlement><country key="NO">NORWAY Norway</country></address></affiliation><affiliation><orgName type="department">Pharmacology Research Lab.</orgName><orgName type="institution">Faculty of Pharmaceutical Sciences</orgName><address><street>University of Science and Technology</street><settlement>Chittagong</settlement><country key="BD">BANGLADESH</country></address></affiliation></author><idno type="istex">E321B47C791B292DD530740F5E0888E20ACF93F8</idno><idno type="ark">ark:/67375/HCB-S6G7H1NF-0</idno><idno type="DOI">10.1007/7081_2007_087</idno></analytic><monogr><title level="m" type="main">Bioactive Heterocycles V</title><idno type="DOI">10.1007/978-3-540-73406-2</idno><idno type="book-id">978-3-540-73406-2</idno><idno type="ISBN">978-3-540-73405-5</idno><idno type="eISBN">978-3-540-73406-2</idno><idno type="chapter-id">Chap6</idno><editor><persName><forename type="first">Mahmud</forename><forename type="first">Tareq</forename><forename type="first">Hassan</forename><surname>Khan</surname></persName><email>mahmud.khan@fagmed.nit.no</email></editor><imprint><biblScope unit="vol">11</biblScope><biblScope unit="page" from="213">213</biblScope><biblScope unit="page" to="229">229</biblScope><biblScope unit="chapter-count">10</biblScope></imprint></monogr><series><title level="s" type="main" xml:lang="en">Topics in Heterocyclic Chemistry</title><idno type="pISSN">1861-9282</idno><idno type="eISSN">1861-9290</idno><idno type="seriesID">7081</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en"><head>Abstract</head><p>Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological
activities, including on different types of cancers. This chapter begins by reviewing some general aspects
of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter
then details several of the latest findings on the activities of quindoline analogs against a number
of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these
analogs, which were proposed by subsequent authors, are also discussed.
</p><figure xml:id="Figa"><media mimeType="image" url=""></media></figure></abstract><textClass ana="keyword"><keywords xml:lang="en"><term>Angiogenesis</term><term>Cancer</term><term>Isoquinoline</term><term>Quindoline</term><term>Quinoline</term><term>Skraup synthesis</term><term>Telomerase</term></keywords></textClass><textClass ana="subject"><keywords scheme="book-subject-collection"><list><label>SUCO11644</label><item><term>Chemistry and Materials Science</term></item></list></keywords></textClass><textClass ana="subject"><keywords scheme="book-subject"><list><label>C</label><item><term type="Primary">Chemistry</term></item><label>C19007</label><item><term type="Secondary" subtype="priority-1">Organic Chemistry</term></item><label>L14005</label><item><term type="Secondary" subtype="priority-2">Biochemistry, general</term></item><label>C28000</label><item><term type="Secondary" subtype="priority-3">Medicinal Chemistry</term></item></list></keywords></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus springer-ebooks not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer Berlin Heidelberg</PublisherName><PublisherLocation>Berlin, Heidelberg</PublisherLocation></PublisherInfo><Series><SeriesInfo SeriesType="Series" TocLevels="0"><SeriesID>7081</SeriesID><SeriesPrintISSN>1861-9282</SeriesPrintISSN><SeriesElectronicISSN>1861-9290</SeriesElectronicISSN><SeriesTitle Language="En">Topics in Heterocyclic Chemistry</SeriesTitle></SeriesInfo><Book Language="En"><BookInfo BookProductType="Reviews" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ContentOnly" TocLevels="0"><BookID>978-3-540-73406-2</BookID><BookTitle>Bioactive Heterocycles V</BookTitle><BookVolumeNumber>11</BookVolumeNumber><BookSequenceNumber>11</BookSequenceNumber><BookDOI>10.1007/978-3-540-73406-2</BookDOI><BookTitleID>150879</BookTitleID><BookPrintISBN>978-3-540-73405-5</BookPrintISBN><BookElectronicISBN>978-3-540-73406-2</BookElectronicISBN><BookChapterCount>10</BookChapterCount><BookCopyright><CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName><CopyrightYear>2007</CopyrightYear></BookCopyright><BookSubjectGroup><BookSubject Code="C" Type="Primary">Chemistry</BookSubject><BookSubject Code="C19007" Priority="1" Type="Secondary">Organic Chemistry</BookSubject><BookSubject Code="L14005" Priority="2" Type="Secondary">Biochemistry, general</BookSubject><BookSubject Code="C28000" Priority="3" Type="Secondary">Medicinal Chemistry</BookSubject><SubjectCollection Code="SUCO11644">Chemistry and Materials Science</SubjectCollection></BookSubjectGroup></BookInfo><BookHeader><EditorGroup><Editor><EditorName DisplayOrder="Western"><GivenName>Mahmud</GivenName><GivenName>Tareq</GivenName><GivenName>Hassan</GivenName><FamilyName>Khan</FamilyName></EditorName><Contact><Email>mahmud.khan@fagmed.nit.no</Email></Contact></Editor></EditorGroup></BookHeader><Chapter ID="Chap6" Language="En"><ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" NumberingStyle="ContentOnly" TocLevels="0"><ChapterID>87</ChapterID><ChapterDOI>10.1007/7081_2007_087</ChapterDOI><ChapterSequenceNumber>6</ChapterSequenceNumber><ChapterTitle Language="En">Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</ChapterTitle><ChapterFirstPage>213</ChapterFirstPage><ChapterLastPage>229</ChapterLastPage><ChapterCopyright><CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName><CopyrightYear>2007</CopyrightYear></ChapterCopyright><ChapterHistory><OnlineDate><Year>2007</Year><Month>9</Month><Day>6</Day></OnlineDate></ChapterHistory><ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ChapterGrants></ChapterInfo><ChapterHeader><AuthorGroup><Author AffiliationIDS="Aff1 Aff2" CorrespondingAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Mahmud</GivenName><GivenName>Tareq</GivenName><GivenName>Hassan</GivenName><FamilyName>Khan</FamilyName></AuthorName><Contact><Email>mahmud.khan@fagmed.uit.no</Email></Contact></Author><Affiliation ID="Aff1"><OrgDivision>School of Molecular and Structural Biology, and Department of Pharmacology</OrgDivision><OrgName>Institute of Medical Biology</OrgName><OrgAddress><Street>University of Tromsø</Street><Postcode>9037</Postcode><City>Tromsø</City><Country>Norway</Country></OrgAddress></Affiliation><Affiliation ID="Aff2"><OrgDivision>Pharmacology Research Lab.</OrgDivision><OrgName>Faculty of Pharmaceutical Sciences</OrgName><OrgAddress><Street>University of Science and Technology</Street><City>Chittagong</City><Country>Bangladesh</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En"><Heading>Abstract</Heading><Para>Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological
activities, including on different types of cancers. This chapter begins by reviewing some general aspects
of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter
then details several of the latest findings on the activities of quindoline analogs against a number
of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these
analogs, which were proposed by subsequent authors, are also discussed.
</Para><Figure Category="Standard" Float="No" ID="Figa"><MediaObject ID="MOESM1"><ImageObject Color="BlackWhite" FileRef="MediaObjects/978-3-540-73406-2_87_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"></ImageObject></MediaObject></Figure></Abstract><KeywordGroup Language="En"><Keyword>Angiogenesis</Keyword><Keyword>Cancer</Keyword><Keyword>Isoquinoline</Keyword><Keyword>Quindoline</Keyword><Keyword>Quinoline</Keyword><Keyword>Skraup synthesis</Keyword><Keyword>Telomerase</Keyword></KeywordGroup></ChapterHeader><NoBody></NoBody></Chapter></Book></Series></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors</title></titleInfo><name type="personal" displayLabel="corresp"><namePart type="given">Mahmud</namePart><namePart type="given">Tareq</namePart><namePart type="given">Hassan</namePart><namePart type="family">Khan</namePart><affiliation>School of Molecular and Structural Biology, and Department of Pharmacology, Institute of Medical Biology, University of Tromsø, 9037, Tromsø, Norway</affiliation><affiliation>Pharmacology Research Lab., Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh</affiliation><affiliation>E-mail: mahmud.khan@fagmed.uit.no</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre displayLabel="OriginalPaper" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" type="research-article" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>Springer Berlin Heidelberg</publisher><place><placeTerm type="text">Berlin, Heidelberg</placeTerm></place><dateIssued encoding="w3cdtf">2007</dateIssued><copyrightDate encoding="w3cdtf">2007</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract lang="en">Abstract: Quinoline and quindoline analogs have been shown to exhibit a wide variety of pharmacological activities, including on different types of cancers. This chapter begins by reviewing some general aspects of quindoline and its analogs, including their potential pharmacological and other general uses. The chapter then details several of the latest findings on the activities of quindoline analogs against a number of specific cancers and tumor subtypes, as well as angiogenesis. Methods of synthesizing several of these analogs, which were proposed by subsequent authors, are also discussed.</abstract><subject lang="en"><topic>Angiogenesis</topic><topic>Cancer</topic><topic>Isoquinoline</topic><topic>Quindoline</topic><topic>Quinoline</topic><topic>Skraup synthesis</topic><topic>Telomerase</topic></subject><relatedItem type="host"><titleInfo><title>Bioactive Heterocycles V</title></titleInfo><name type="personal"><namePart type="given">Mahmud</namePart><namePart type="given">Tareq</namePart><namePart type="given">Hassan</namePart><namePart type="family">Khan</namePart><role><roleTerm type="text">editor</roleTerm></role></name><genre type="book-series" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0G6R5W5T-Z">book-series</genre><originInfo><publisher>Springer</publisher><copyrightDate encoding="w3cdtf">2007</copyrightDate><issuance>monographic</issuance></originInfo><subject><genre>Book-Subject-Collection</genre><topic authority="SpringerSubjectCodes" authorityURI="SUCO11644">Chemistry and Materials Science</topic></subject><subject><genre>Book-Subject-Group</genre><topic authority="SpringerSubjectCodes" authorityURI="C">Chemistry</topic><topic authority="SpringerSubjectCodes" authorityURI="C19007">Organic Chemistry</topic><topic authority="SpringerSubjectCodes" authorityURI="L14005">Biochemistry, general</topic><topic authority="SpringerSubjectCodes" authorityURI="C28000">Medicinal Chemistry</topic></subject><identifier type="DOI">10.1007/978-3-540-73406-2</identifier><identifier type="ISBN">978-3-540-73405-5</identifier><identifier type="eISBN">978-3-540-73406-2</identifier><identifier type="ISSN">1861-9282</identifier><identifier type="eISSN">1861-9290</identifier><identifier type="BookTitleID">150879</identifier><identifier type="BookID">978-3-540-73406-2</identifier><identifier type="BookChapterCount">10</identifier><identifier type="BookVolumeNumber">11</identifier><identifier type="BookSequenceNumber">11</identifier><part><date>2007</date><detail type="volume"><number>11</number><caption>vol.</caption></detail><extent unit="pages"><start>213</start><end>229</end></extent></part><recordInfo><recordOrigin>Springer-Verlag Berlin Heidelberg, 2007</recordOrigin></recordInfo></relatedItem><relatedItem type="series"><titleInfo><title>Topics in Heterocyclic Chemistry</title></titleInfo><originInfo><publisher>Springer</publisher><copyrightDate encoding="w3cdtf">2007</copyrightDate><issuance>serial</issuance></originInfo><identifier type="ISSN">1861-9282</identifier><identifier type="eISSN">1861-9290</identifier><identifier type="SeriesID">7081</identifier><recordInfo><recordOrigin>Springer-Verlag Berlin Heidelberg, 2007</recordOrigin></recordInfo></relatedItem><identifier type="istex">E321B47C791B292DD530740F5E0888E20ACF93F8</identifier><identifier type="ark">ark:/67375/HCB-S6G7H1NF-0</identifier><identifier type="DOI">10.1007/7081_2007_087</identifier><identifier type="ChapterID">87</identifier><identifier type="ChapterID">Chap6</identifier><accessCondition type="use and reproduction" contentType="copyright">Springer-Verlag Berlin Heidelberg, 2007</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-RLRX46XW-4">springer</recordContentSource><recordOrigin>Springer-Verlag Berlin Heidelberg, 2007</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/record.json</uri></json:item></metadata><annexes><json:item><extension>txt</extension><original>true</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/HCB-S6G7H1NF-0/annexes.txt</uri></json:item></annexes></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B42 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B42 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:E321B47C791B292DD530740F5E0888E20ACF93F8
|texte= Quinoline Analogs as Antiangiogenic Agents and Telomerase Inhibitors
}}
| This area was generated with Dilib version V0.6.33. |  |